Loomis, Sayles & Company’s CDK Global, Inc. CDK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-202,041
Closed -$11.1M 1073
2022
Q2
$11.1M Sell
202,041
-60,015
-23% -$3.24M 0.02% 338
2022
Q1
$12.8M Buy
262,056
+3,193
+1% +$143K 0.02% 344
2021
Q4
$10.8M Sell
258,863
-10,598
-4% -$445K 0.01% 375
2021
Q3
$11.5M Sell
269,461
-3,633
-1% -$164K 0.01% 373
2021
Q2
$13.6M Buy
273,094
+10,923
+4% +$578K 0.02% 352
2021
Q1
$14.2M Buy
262,171
+81,792
+45% +$4.24M 0.02% 334
2020
Q4
$9.35M Buy
+180,379
New +$8.56M 0.01% 384
2015
Q2
Sell
-10
Closed 953
2015
Q1
$0 Hold
10
﹤0.01% 781
2014
Q4
$0 Buy
+10
New +$354 ﹤0.01% 767

Other funds holding CDK

Loomis, Sayles & Company's CDK Position: Q3 2022 in Review

Loomis, Sayles & Company sold out of CDK Global, Inc. (CDK) in Q3 2022, closing a stake of 202,041 shares — an estimated $11.1M sold.

Loomis, Sayles & Company first reported a position in CDK in Q4 2014 and held it in 9 quarters. The position peaked at $14.2M in Q1 2021. 6 funds tracked by Wall St. Rank hold CDK as of Q3 2022.

  • Loomis, Sayles & Company reported no remaining CDK Global, Inc. position as of Q3 2022 after selling out during the quarter.
  • Loomis, Sayles & Company sold 202,041 CDK Global, Inc. shares in Q3 2022, an estimated $11.1M.
  • Loomis, Sayles & Company first reported a position in CDK Global, Inc. in Q4 2014 and held it in 9 quarters.
  • Loomis, Sayles & Company's CDK Global, Inc. position peaked at $14.2M in Q1 2021.
  • 6 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q3 2022.

Based on Loomis, Sayles & Company's 13F filing for Q3 2022, filed 14 Nov 2022.